D-0305-2020 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- November 13, 2019
- Initiation Date
- November 1, 2019
- Termination Date
- March 4, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 30,516 bottles
Product Description
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10
Reason for Recall
Presence of Foreign substance: identified as a dead ant.
Distribution Pattern
Product was distributed to major distributors/wholesalers throughout the United States.
Code Information
Lot #: F802345, F802346, F802347, Exp 11/20